Sun.Jan 28, 2024

article thumbnail

Episode 891: The Half-Dose Alteplase Study You’ve Always Wanted

Pharmacy Joe

In this episode, I’ll discuss an article comparing half-dose to full-dose alteplase for pulmonary embolism. Episode 891: The Half-Dose Alteplase Study You’ve Always Wanted Subscribe on iTunes , Android , or Stitcher Members of the Hospital Pharmacy Academy have access to trainings on how to run a journal club, and biostatistics for journal club in addition to hundreds of other trainings to help you in your practice.

article thumbnail

‘I don’t see how it ends’: expert sounds alarm on new wave of US opioids crisis

The Guardian - Pharmaceutical Industry

Dr Art Van Zee set out in the early 2000s to tell anyone who would listen how a powerful opioid was destroying lives. Two decades later, he’s still in disbelief When Dr Art Van Zee finally understood the scale of the disaster looming over his corner of rural Virginia, he naively imagined the drug industry would be just as alarmed. So the longest serving doctor in the struggling former mining town of St Charles set out in the early 2000s to tell pharmaceutical executives, federal regulators, Cong

95
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

CHMP turns down Neuraxpharm, Apellis drugs

pharmaphorum

The CHMP has rejected marketing approvals for two drugs from Neuraxpharm and Apellis, but the pharma companies say they will appeal

94
article thumbnail

Outlining the Legal Arguments Against FDA’s Proposed Rule Regulating LDTs

FDA Law Blog: Biosimilars

By Jeffrey N. Gibbs & Steven J. Gonzalez — In a new publication in the Washington Legal Foundation’s (WLF) Legal Backgrounder , we argue that FDA’s recent proposed rule regulating Laboratory Developed Tests (LDTs) is vulnerable to legal challenge, once finalized. FDA’s proposed rule has every hallmark of a case subject to the “major questions doctrine,” according to which agency action must be support by clear congressional authorization.

64
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Alternative buffer management strategies to achieve downstream process improvements

PharmaTech

Buffers are used in great quantities when producing monoclonal antibodies (mAbs), and many biopharmaceutical companies — even large ones — do not have the processing capacity or infrastructure in-house to handle these large volumes. Whether it’s providing quality, pre-weighed, GMP-compliant raw materials or the entire buffer preparation step, there are options available to optimize your process.

article thumbnail

Prednisone Versus Prednisolone

Med Ed 101

Many often wonder when to use prednisone versus prednisolone and why we may see one over the other prescribed in practice. They are not the same medication and have their differences, but they also share a lot of similarities. To make it simple it is often about what is the easiest dosage form for the […] The post Prednisone Versus Prednisolone appeared first on Med Ed 101.

Dosage 52

More Trending

article thumbnail

Eczematous Cheilitis

RX Note

Introduction Eczematous cheilitis, also known as lip dermatitis, is inflammation of the lips presenting as redness with dryness and scaling. The major causes of eczematous cheilitis are atopic dermatitis and irritant or allergic contact reactions. Symptoms Unlike simple dry lips, eczematous cheilitis is significantly more severe. The lips are typically intensely chapped, and may also be inflamed and scaly.

40
article thumbnail

Solving Cost and Supply Challenges in Biopharma Downstream Processing

PharmaTech

As the most expensive stage of monoclonal antibody production, downstream processing presents numerous opportunities to increase efficiency and raw material performance. This article discusses advances in purification process materials, as well as emerging technologies to aggregate and analyze data, as possible solutions to these challenges.

40
article thumbnail

Which pharmaceutical companies have the most concentrate dosed drugs?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most concentrate dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most concentrate dosed drugs… The post Which pharmaceutical companies have the most concentrate dosed drugs? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

Particulate Matters: Categorizations, Considerations, and Compendia

PharmaTech

Webinar Date/Time: Wed, Mar 6, 2024 10:00 AM EST

52
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

The New Pharmacy Model

pharmacy mentor

The New Pharmacy Model Pharmacies in the United Kingdom are undergoing a profound transformation. Gone are the days of simply dispensing medicine from the back of the pharmacy. The emergence of new compliance standards and regulations, alongside advancements in technology and a shift towards more patient-centric care, has paved the way for what can be aptly termed as “The New Pharmacy Model” This model, envisioned by our CEO, Saam Ali, encompasses a comprehensive approach to pharmacy